These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27119007)

  • 1. Metforminium Decavanadate as a Potential Metallopharmaceutical Drug for the Treatment of Diabetes Mellitus.
    Treviño S; Velázquez-Vázquez D; Sánchez-Lara E; Diaz-Fonseca A; Flores-Hernandez JÁ; Pérez-Benítez A; Brambila-Colombres E; González-Vergara E
    Oxid Med Cell Longev; 2016; 2016():6058705. PubMed ID: 27119007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metforminium Decavanadate (MetfDeca) Treatment Ameliorates Hippocampal Neurodegeneration and Recognition Memory in a Metabolic Syndrome Model.
    Diaz A; Muñoz-Arenas G; Venegas B; Vázquez-Roque R; Flores G; Guevara J; Gonzalez-Vergara E; Treviño S
    Neurochem Res; 2021 May; 46(5):1151-1165. PubMed ID: 33559829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemic, lipid-lowering and metabolic regulation activities of metforminium decavanadate (H2Metf)3 [V10O28]·8H2O using hypercaloric-induced carbohydrate and lipid deregulation in Wistar rats as biological model.
    Treviño S; Sánchez-Lara E; Sarmiento-Ortega VE; Sánchez-Lombardo I; Flores-Hernández JÁ; Pérez-Benítez A; Brambila-Colombres E; González-Vergara E
    J Inorg Biochem; 2015 Jun; 147():85-92. PubMed ID: 25920353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
    Liu Z; Li J; Zeng Z; Liu M; Wang M
    Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyoxidovanadates as a pharmacological option against brain aging.
    Díaz A; Vázquez-Roque R; Carreto-Meneses K; Moroni-González D; Moreno-Rodríguez JA; Treviño S
    J Chem Neuroanat; 2023 Apr; 129():102256. PubMed ID: 36921908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes.
    Cam MC; Cros GH; Serrano JJ; Lazaro R; McNeill JH
    Diabetes Res Clin Pract; 1993 May; 20(2):111-21. PubMed ID: 8375263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
    Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
    Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
    Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
    Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of Terminalia chebula Retz. on hyperglycemia and associated hyperlipidemia, tissue glycogen content and in vitro release of insulin in streptozotocin induced diabetic rats.
    Murali YK; Anand P; Tandon V; Singh R; Chandra R; Murthy PS
    Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):641-6. PubMed ID: 18058598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
    Yao J; Battell ML; McNeill JH
    Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tea/vanadate decoction delivered orally over 14 months to diabetic rats induces long-term glycemic stability without organ toxicity.
    Clark TA; Heyliger CE; Kopilas M; Edel AL; Junaid A; Aguilar F; Smyth DD; Thliveris JA; Merchant M; Kim HK; Pierce GN
    Metabolism; 2012 May; 61(5):742-53. PubMed ID: 22146096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of D-400, a herbomineral preparation on lipid profile, glycated haemoglobin and glucose tolerance in streptozotocin induced diabetes in rats.
    Mitra SK; Gopumadhavan S; Muralidhar TS; Anturlikar SD; Sujatha MB
    Indian J Exp Biol; 1995 Oct; 33(10):798-800. PubMed ID: 8575814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes.
    Cam MC; Rodrigues B; McNeill JH
    Eur J Endocrinol; 1999 Nov; 141(5):546-54. PubMed ID: 10576774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ameliorating effect of eugenol on hyperglycemia by attenuating the key enzymes of glucose metabolism in streptozotocin-induced diabetic rats.
    Srinivasan S; Sathish G; Jayanthi M; Muthukumaran J; Muruganathan U; Ramachandran V
    Mol Cell Biochem; 2014 Jan; 385(1-2):159-68. PubMed ID: 24078031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapy with metformin and insulin attenuates systemic and hepatic alterations in a model of high-fat diet-/streptozotocin-induced diabetes.
    Silvares RR; Pereira EN; Flores EE; Estato V; Reis PA; Silva IJ; Machado MP; Neto HC; Tibiriça E; Daliry A
    Int J Exp Pathol; 2016 Jun; 97(3):266-77. PubMed ID: 27381700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyherbal mixture ameliorates hyperglycemia, hyperlipidemia and histopathological changes of pancreas, kidney and liver in a rat model of type 1 diabetes.
    Madić V; Petrović A; Jušković M; Jugović D; Djordjević L; Stojanović G; Vasiljević P
    J Ethnopharmacol; 2021 Jan; 265():113210. PubMed ID: 32795501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanadyl-biguanide complexes as potential synergistic insulin mimics.
    Woo LC; Yuen VG; Thompson KH; McNeill JH; Orvig C
    J Inorg Biochem; 1999 Sep; 76(3-4):251-7. PubMed ID: 10605840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of diabegon, a polyherbal preparation, during progression of diabetes induced by high-fructose feeding in rats.
    Yadav H; Jain S; Prasad GB; Yadav M
    J Pharmacol Sci; 2007 Sep; 105(1):12-21. PubMed ID: 17878707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel formula Sang-Tong-Jian improves glycometabolism and ameliorates insulin resistance by activating PI3K/AKT pathway in type 2 diabetic KKAy mice.
    Kuai M; Li Y; Sun X; Ma Z; Lin C; Jing Y; Lu Y; Chen Q; Wu X; Kong X; Bian H
    Biomed Pharmacother; 2016 Dec; 84():1585-1594. PubMed ID: 27829545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.